Literature DB >> 8674363

Use or misuse of colostomy to heal pressure ulcers.

G R Deshmukh1, D C Barkel, D Sevo, P Hergenroeder.   

Abstract

PURPOSE: The purpose of this study is to evaluate the effectiveness of colostomy performed as an adjunct measure in the attempt to heal pressure ulcers by flap closure.
METHODS: Twenty-seven consecutive patients who underwent colostomy for healing of pressure ulcers were studied by chart review and patient questionnaire. Fecal diversion was accomplished by colostomy in each case.
RESULTS: There were four (15 percent) deaths. Twenty-three patients subsequently underwent flap closure of their ulcer. Of 19 patients available for follow-up, only 6 (32 percent) patients had completely healed, although most patients thought their quality of life improved because of the colostomy. None of the patients underwent colostomy closure.
CONCLUSION: Our conclusions are that, although most patients will have an improved quality of life subsequent to diversion, the high mortality and low rate of pressure ulcer healing should temper enthusiasm for performing colostomy in this setting.

Entities:  

Mesh:

Year:  1996        PMID: 8674363     DOI: 10.1007/bf02054436

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  2 in total

1.  A case of simultaneous abdominal wall reconstruction and creation of diverting ostomy in a ventral hernia with loss of domain.

Authors:  Robert DeVito; Sameh Shoukry; Benjamin Yglesias; Rhett Fullmer; Brandon Zarnoth; Thomas Kerestes
Journal:  Int J Surg Case Rep       Date:  2020-10-07

2.  Pressure ulcer-related pelvic osteomyelitis: evaluation of a two-stage surgical strategy (debridement, negative pressure therapy and flap coverage) with prolonged antimicrobial therapy.

Authors:  Johan Andrianasolo; Tristan Ferry; Fabien Boucher; Joseph Chateau; Hristo Shipkov; Fatiha Daoud; Evelyne Braun; Claire Triffault-Fillit; Thomas Perpoint; Frédéric Laurent; Alain-Ali Mojallal; Christian Chidiac; Florent Valour
Journal:  BMC Infect Dis       Date:  2018-04-10       Impact factor: 3.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.